Request an Appointment
Find a Center
Contact Us

David S. Liao, M.D.

“It is an honor and privilege to be a part of my patients’ lives - trying to help them see better one visit at a time. If we all treat each other how we would like to be treated, the world can be a little better place.”


Dr. David S. Liao is a board-certified ophthalmologist specializing in the medical and surgical treatment of diseases of the retina and vitreous. His main areas of interest include macular degeneration, diabetic retinopathy, disorders of the vitreomacular interface, and retinal detachment repair. Dr. Liao is a recognized leader in his field.  He has been involved in research studies involving retinal diseases such as macular degeneration, diabetic retinopathy, and retinal vein occlusions. He has authored and co-authored a number of publications and abstracts relating to both clinical conditions and basic science research. Dr. Liao approaches patients with kindness and compassion and looks forward to serving you.


Education and Training

  • College
    B.S. Biology, University of Maryland, College Park, MD (1997)
    M.S. Electricall Engineering, University of Maryland, College Park, MD (1996)
  • Medical School
    Ph.D, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA (2003)
  • Internship
    Transitional Internship, Riverside Medical Center, Newport News, VA (2004)
  • Residency Training in Ophthalmology
    Ophthalmology Residency, University of Texas at Dallas Southwestern Medical Center, Dallas, TX (2007)
  • Vitreo Retinal Fellowship
    Tufts Medical Center, Ophthalmic Consultants of Boston, Boston, MA (2009)

Professional Affiliations

  • Board Certified – American Board of Ophthalmology
  • American Academy of Ophthalmology
  • Massachusetts Medical Society

Publications and Presentations

1. Liao DS, Prusky GT, Mower AF, Ramoa AS
“Cortical recovery from monocular deprivation in ferrets.”
Soc Neurosci Abstr. 2000; 26: 164.

2. Prusky GT, Liao DS, Mower AF, Ramoa AS
“NMDA receptor-dependent loss of binocularity in strabismic ferrets”
Soc Neurosci Abstr. 2000; 26: 164.

3. Medina AE, Liao DS, Mower AF, Ramoa AS
“Do NMDA receptor kinetics regulate the end of critical periods of plasticity?”
Neuron. 2001; 32: 553-555.

4. Ramoa AS, Mower AF, Liao D, Jafri S
“Suppression of cortical NMDA receptor function prevents development of orientation selectivity in the primary visual cortex”
J Neurosci. 2001; 21:4299-4309.

5. Liao DS, Mower AF, Medina AE, Neve RL, Ramoa AS “Cortical recovery from monocular deprivation in ferrets” Soc Neurosci Abstr. 2001; 27: 244.

6. Mower AF, Liao DS, Neve RL, Ramoa AS
“GREB function is essential for ocular dominance plasticity”
Soc Neurosci Abstr. 2001; 27:244.

7. Liao DS, Mower AF, Neve RL, Sato-Bigbee C, Ramoa AS
“Different mechanisms for loss and recovery of binocularity in the visual cortex”
J Neurosci. 2002; 22:9015-23.

8. Mower AF, Liao OS, Nestler EJ, Neve RL, Ramoa AS
“cAMP/CA2+ response element-binding protein function is essential for ocular dominance plasticity”
J Neurosci. 2002; 22: 2237-2245.

9. Liao OS, Mower AF, Sato-Bigbee C, Neve RL, Ramoa AS “Mechanisms of cortical”
Abstract 2003; 4108/8811.

10. Liao OS, Krahe TE, Prusky GT, Medina AE, Ramoa AS.
“Recovery of cortical binocularity and orientation selectivity after the critical period for ocular dominance plasticity”
J Neurophysio/. 2004; 92(4):2113-21.

11. He YG, Liao 0, Zhao B, Owens J, Johnston JM.
“Evidence for a role of platelet-activating factor (PAF) in the pathogenesis of age-related macular degeneration (AMD)”
Invest Ophthalmo/ Vis Sci. 2007;47: ARVO E-Abstract 2200/8809.


12. Liao DS, Heier JS
“Outcomes of combined vitreoretinal and anterior segment procedures.”
Invest Ophthalmol. 2008;Vis Sci 48: ARVO E-Abstract 5989/A454.

13. Nguyen JK, Heier JS, Liao DS
“Reproducibility of retinal thickness measurements using Heidelberg spectral domain versus Status OCT.”
Invest Ophthalmol Vis Sci. 2008;48: ARVO E-Abstract 917/0747.

14. He YG, Wang H, Zhao B, Hsu M, Liao D, Owens J, Johnston J
“Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells.”
Current Eye Research. 2009; 34(11):957-65.

15. Carle MV, Boyer OS, Chu TG, Rahhal F, Novack RL, Roe RH, Dayani PN, Liao DS, Walsh AC.
“Treatment Extension and Visual Outcomes of Anti-VEGF Therapy with Ranibizumab or Aflibercept for Neovascular Age-Related Macular Degeneration (nvAMD)”
Poster at: ASRS Toronto. 2013

16. Carle MV, Boyer OS, Liao D, Chu T.
“Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with Chroidal Osteoma”
Ophthalmic Surg Lasers Imaging Retina. 2014;45(2):XXX-X

Awards and Achievements

  • Dr. Liao has been named as a Castle Connolly Regional Top Doctors

    Castle Connolly is America’s trusted source for the identification of Top Doctors. Their physician-led research team reviews and screens the credentials of tens of thousands of physicians who are nominated by their peers annually, via a nationwide online process, before selecting those physicians who are regionally or nationally among the very best in their medical specialties. Castle Connolly believes strongly that Top Doctors Make a Difference™.

Common Vision Challenges by Age

20 - 40
Are you tired of glasses & contacts?
Are you curious about LASIK vision correction?

Take Our Free LASIK Self-Evaluation
40 - 50
Has your up-close vision become blurry?
Do you need reading glasses to see menus, text messages, labels, etc.?
Are you experiencing cloudy, yellowed vision?
Have you been diagnosed with cataracts?

Take Our Free Cataract Self-Evaluation